Author:
Thompson Brian R.,Shi Jian,Zhu Hao-Jie,Smith David E.
Funder
National Institutes of Health
National Institute of General Medical Sciences
Subject
Pharmacology,Biochemistry
Reference40 articles.
1. Gemzar [package insert]. Eli Lilly and Company, Indianapolis, IN, (2014).
2. Prevalence of Off-Label Use and Spending in 2010 Among Patent-Protected Chemotherapies in a Population-Based Cohort of Medical Oncologists;Conti;J. Clin. Oncol.,2013
3. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer;Valle;N. Engl. J Med.,2010
4. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer;von der Maase;J. Clin. Oncol.,2005
5. Action of 2',2'-difluorodeoxycytidine on DNA synthesis;Huang;Cancer Res.,1991
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献